Literature DB >> 6819349

The hematopoietic defect of the jaws: a report of sixteen cases.

C S Lipani, J R Natiella, G W Greene.   

Abstract

Biopsy of radiolucent lesions of the jaws has resulted in the identification of areas of hematopoiesis usually designated as focal osteoporotic marrow defects. The majority of the cases reported involve the posterior region of the mandible in a previous extraction site. Pain and swelling are not uncommon. Since the clinical and radiographic symptoms of hematopoietic defects resemble manifestations of other neoplastic and inflammatory diseases, it is important to continue to describe the properties of this interesting entity.

Entities:  

Mesh:

Year:  1982        PMID: 6819349     DOI: 10.1111/j.1600-0714.1982.tb00184.x

Source DB:  PubMed          Journal:  J Oral Pathol        ISSN: 0300-9777


  4 in total

1.  Ultrasound Sonography to Detect Focal Osteoporotic Jawbone Marrow Defects Clinical Comparative Study with Corresponding Hounsfield Units and RANTES/CCL5 Expression.

Authors:  Johann Lechner; Bernd Zimmermann; Marlene Schmidt; Volker von Baehr
Journal:  Clin Cosmet Investig Dent       Date:  2020-06-02

2.  Displacement of dental implants into the focal osteoporotic bone marrow defect: a report of three cases.

Authors:  Sang-Chil Lee; Chang-Hwa Jeong; Ho-Yong Im; Seong-Young Kim; Jae-Young Ryu; Hak-Yeol Yeom; Hyeon-Min Kim
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2013-04-23

3.  Bilateral osteoporotic bone marrow defects of the mandible: a case report.

Authors:  Diego Mauricio Bravo-Calderón; Denise Tostes Oliveira; Wagner Humberto Martins Dos Santos
Journal:  Head Face Med       Date:  2012-08-08       Impact factor: 2.151

4.  Immunohistological staining of unknown chemokine RANTES/CCL5 expression in jawbone marrow defects-osteoimmunology and disruption of bone remodeling in clinical case studies targeting on predictive preventive personalized medicine.

Authors:  Johann Lechner; Tilman Schulz; Volker von Baehr
Journal:  EPMA J       Date:  2019-08-06       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.